Philipp Martin advises prominent financial sponsors and corporates on cross-border M&A transactions, predominantly in the business services, technology, and industrial sectors. He represents clients on investments in private and public companies, joint ventures, co- and re-investments, management participation programs, and preferred equity or hybrid investments. His also provides strategic legal advice on corporate law matters, and he gained significant in-house experience during a secondment to the investment legal team of a European large cap private equity house.
Prior to joining Jones Day in 2025, Philipp represented Riverside on the investment into GFOS, a software provider in the areas of workforce management, access control, and manufacturing execution systems; Nimbus Private Equity on the sale of Extrusion Technology Group to Gamut Capital's portfolio company Davis-Standard; Brookfield Asset Management on the intended acquisition of a testing and inspection business in the oil and gas infrastructure space; a consortium comprising of Life Sciences Partners (now EQT Life Sciences), HealthCap, and Pureos Bioventures on the carve-out of Ariceum Therapeutics from pharma company Ipsen; Charterhouse Capital Partners on the acquisition of telecommunications company Telio Management from DBAG; Advent International on the sale of allnex group to PTT Global Chemical; APAX Partners on various matters, including the acquisition of WSGN from Ascential; and Centerbridge on several matters, including Auxmoney and the intended acquisition of a stake in Norddeutsche Landesbank.
- Upper Regional Court Frankfurt (Second State Examination 2021); Goethe University Frankfurt (First State Examination 2018)
- Federal Republic of Germany
- English and German